Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Xinmingda Bio-Pharmaceutical is a Chinese biotechnology company headquartered in Haikou, Hainan Province. Founded in 2021, the company is situated within the Hainan Free Trade Port, leveraging regional incentives to advance the research and development of innovative small molecule drugs and biological products. Its primary focus includes the development of therapies for viral infections and the production of high-quality active pharmaceutical ingredients (APIs). The company provides a range of services including technology transfer, technical consulting, and pharmaceutical wholesale. Hainan Xinmingda is currently in the pre-clinical stage of development, focusing on building a robust R&D pipeline tailored to unmet medical needs in the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Xinmingda Bio-Pharmaceutical.